Frontiers Cognitive impairment after long COVID-19: current evidence and perspectives

Two Years into the COVID-19 Pandemic: Lessons Learned

Frontiers Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data

Frontiers Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome

Frontiers COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management

Frontiers The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue

JCM, Free Full-Text

Frontiers COVID-19 Adaptive Interventions: Implications for Wellbeing and Quality-of-Life

Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis

Frontiers Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes - eBioMedicine

COVID‐19 and the impact on Alzheimer's disease pathology - Furman - Journal of Neurochemistry - Wiley Online Library

Frontiers Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

Potential for Cognitive Communication Impairment in COVID-19 Survivors: A Call to Action for Speech-Language Pathologists

Frontiers COVCOG 1: Factors Predicting Physical, Neurological and Cognitive Symptoms in Long COVID in a Community Sample. A First Publication From the COVID and Cognition Study